• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者肌少症的患病率和非药物干预措施。

Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients.

机构信息

Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia.

Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt.

出版信息

Dis Markers. 2021 Feb 4;2021:8866093. doi: 10.1155/2021/8866093. eCollection 2021.

DOI:10.1155/2021/8866093
PMID:33628339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884167/
Abstract

Sarcopenia is the most common feature of hepatic cirrhosis characterized by progressive loss of muscle mass and function and increases permanently the mortality and morbidity rates among those patients. The incidence of sarcopenia in cirrhotic patients ranged 40-70% associating with impaired quality of life and augmented rates of infection. Based on these issues, this review is aimed at determining the prevalence and main causes of sarcopenia among cirrhotic patients and recognizing the recent diagnostic and physical treatment modalities that prevent risk factors for sarcopenia in those patients. No ideal modality is currently demonstrated for diagnosing sarcopenia in hepatic diseases, particularly cirrhosis; however, recent studies reported different diagnostic modalities for muscle function in different individuals including handgrip strength, skeletal muscle index, six-min walk test, liver frailty index, short physical performance battery, and radiological assessments for quadriceps and psoas muscles. Exercise training and therapeutic nutrition are strongly recommended for controlling sarcopenia in cirrhotic patients. The exercise program is designed and carried out on a frequent basis within an extensive scheduled time aimed at improving functional performance, aerobic capacity, and healthy conditions. Finally, a combination of exercise training and therapeutic nutrition is powerfully recommended to control sarcopenia in cirrhosis.

摘要

肌肉减少症是肝硬化最常见的特征,其表现为肌肉质量和功能进行性丧失,并永久性地增加这些患者的死亡率和发病率。肝硬化患者中肌肉减少症的发生率为 40-70%,与生活质量受损和感染率增加有关。基于这些问题,本综述旨在确定肝硬化患者中肌肉减少症的患病率和主要原因,并认识到最近用于预防这些患者肌肉减少症风险因素的诊断和物理治疗方法。目前尚无用于诊断肝脏疾病(尤其是肝硬化)中肌肉减少症的理想方法;然而,最近的研究报告了针对不同个体肌肉功能的不同诊断方法,包括握力、骨骼肌指数、六分钟步行试验、肝脏脆弱指数、简短体能测试、股四头肌和腰大肌的影像学评估。运动训练和治疗性营养强烈推荐用于控制肝硬化患者的肌肉减少症。运动方案是在广泛的预定时间内频繁设计和进行的,旨在改善功能表现、有氧能力和健康状况。最后,强烈推荐将运动训练和治疗性营养相结合,以控制肝硬化中的肌肉减少症。

相似文献

1
Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients.肝硬化患者肌少症的患病率和非药物干预措施。
Dis Markers. 2021 Feb 4;2021:8866093. doi: 10.1155/2021/8866093. eCollection 2021.
2
Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge.肝脏疾病中肌肉减少症的分子机制与治疗:现有知识综述。
Int J Mol Sci. 2021 Jan 31;22(3):1425. doi: 10.3390/ijms22031425.
3
Clinical relevance of sarcopenia in patients with cirrhosis.肝硬化患者中肌肉减少症的临床相关性。
World J Gastroenterol. 2014 Jul 7;20(25):8061-71. doi: 10.3748/wjg.v20.i25.8061.
4
The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study.补充 12 周 β-羟基-β-甲基丁酸对肝硬化患者的影响:一项随机对照单盲先导研究的结果。
Nutrients. 2021 Jul 2;13(7):2296. doi: 10.3390/nu13072296.
5
Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans.肝硬化患者的肌肉减少性肥胖:两种预后巨头的融合。
Liver Int. 2018 Oct;38(10):1706-1717. doi: 10.1111/liv.13876. Epub 2018 May 25.
6
Effect of a 12-week home-based exercise training program on aerobic capacity, muscle mass, liver and spleen stiffness, and quality of life in cirrhotic patients: a randomized controlled clinical trial.一项为期 12 周的基于家庭的运动训练计划对肝硬化患者有氧能力、肌肉质量、肝脾硬度和生活质量的影响:一项随机对照临床试验。
BMC Gastroenterol. 2022 Feb 14;22(1):66. doi: 10.1186/s12876-022-02147-7.
7
Sarcopenia and chronic liver diseases.肌肉减少症与慢性肝脏疾病。
Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1229-1244. doi: 10.1080/17474124.2018.1534586. Epub 2018 Oct 16.
8
Sarcopenia and Frailty in Cirrhosis: Assessment and Management.肝硬化相关的肌肉减少症和衰弱:评估和管理。
Med Clin North Am. 2023 May;107(3):589-604. doi: 10.1016/j.mcna.2022.12.007. Epub 2023 Feb 20.
9
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.北美专家关于肝移植中肌肉减少症的观点声明。
Hepatology. 2019 Nov;70(5):1816-1829. doi: 10.1002/hep.30828. Epub 2019 Aug 19.
10
Nutrition and exercise in the management of liver cirrhosis.肝硬化管理中的营养与运动
World J Gastroenterol. 2014 Jun 21;20(23):7286-97. doi: 10.3748/wjg.v20.i23.7286.

引用本文的文献

1
Relationship between Circadian System Status, Child-Pugh Score, and Clinical Outcome in Cirrhotic Patients on Waiting Lists for Liver Transplantation.肝移植等待名单上肝硬化患者的昼夜节律系统状态、Child-Pugh评分与临床结局的关系
J Clin Med. 2024 Aug 2;13(15):4529. doi: 10.3390/jcm13154529.
2
Assessing the risk factors associated with sarcopenia in patients with liver cirrhosis: a case-control study.评估肝硬化患者肌少症相关的危险因素:一项病例对照研究。
Sci Rep. 2023 Dec 9;13(1):21845. doi: 10.1038/s41598-023-48955-z.

本文引用的文献

1
Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis.使用日本肝病学会(JSH)、亚洲肌肉减少症工作组(AWGS)和欧洲老年人肌肉减少症工作组(EWGSOP2)标准对肝硬化患者肌肉减少症进行比较评估以及肌肉减少症、骨质疏松症和骨肌减少症之间的关系
BMC Musculoskelet Disord. 2019 Dec 26;20(1):615. doi: 10.1186/s12891-019-2983-4.
2
Muscle psoas indices measured by ultrasound in cirrhosis - Preliminary evaluation of sarcopenia assessment and prediction of liver decompensation and mortality.超声测量肝硬化患者的腰肌指数 - 肌肉减少症评估和预测肝失代偿及死亡率的初步评估。
Dig Liver Dis. 2019 Nov;51(11):1502-1507. doi: 10.1016/j.dld.2019.08.017. Epub 2019 Sep 20.
3
Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis.握力降低可预测肝硬化患者的不良生存:一项性别分层分析。
Hepatol Res. 2019 Dec;49(12):1414-1426. doi: 10.1111/hepr.13420. Epub 2019 Oct 9.
4
Exercise prescription in patients with cirrhosis: Recommendations for clinical practice.肝硬化患者的运动处方:临床实践建议
Rev Gastroenterol Mex (Engl Ed). 2019 Jul-Sep;84(3):326-343. doi: 10.1016/j.rgmx.2019.02.011. Epub 2019 Jun 28.
5
Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk.应用双能 X 线吸收法检测在晚期肝硬化患者中预测与肌肉减少症相关的死亡风险。
Liver Int. 2019 Jun;39(6):1089-1097. doi: 10.1111/liv.14071. Epub 2019 Feb 25.
6
Are Predictive Energy Expenditure Equations Accurate in Cirrhosis?预测能量消耗方程在肝硬化中准确吗?
Nutrients. 2019 Feb 4;11(2):334. doi: 10.3390/nu11020334.
7
Assessment of Muscle Wasting in Long-Stay ICU Patients Using a New Ultrasound Protocol.使用新的超声协议评估长期 ICU 患者的肌肉减少症。
Nutrients. 2018 Dec 1;10(12):1849. doi: 10.3390/nu10121849.
8
Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease.肌肉减少症和衰弱症对非酒精性脂肪性肝炎和酒精性肝病的影响不同。
Liver Transpl. 2019 Jan;25(1):14-24. doi: 10.1002/lt.25346.
9
EASL Clinical Practice Guidelines on nutrition in chronic liver disease.EASL 临床实践指南:慢性肝病中的营养问题。
J Hepatol. 2019 Jan;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024. Epub 2018 Aug 23.
10
Liver cirrhosis.肝硬化
Lancet. 2018 Jul 28;392(10144):275. doi: 10.1016/S0140-6736(18)31659-3.